PL2338059T3 - Ligandy dla zagregowanych cząsteczek tau - Google Patents
Ligandy dla zagregowanych cząsteczek tauInfo
- Publication number
- PL2338059T3 PL2338059T3 PL09785147T PL09785147T PL2338059T3 PL 2338059 T3 PL2338059 T3 PL 2338059T3 PL 09785147 T PL09785147 T PL 09785147T PL 09785147 T PL09785147 T PL 09785147T PL 2338059 T3 PL2338059 T3 PL 2338059T3
- Authority
- PL
- Poland
- Prior art keywords
- ligands
- aggregated tau
- tau molecules
- molecules
- aggregated
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/18—Sulfur containing
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9937608P | 2008-09-23 | 2008-09-23 | |
| PCT/GB2009/002260 WO2010034982A1 (en) | 2008-09-23 | 2009-09-23 | Ligands for aggregated tau molecules |
| EP09785147.1A EP2338059B1 (en) | 2008-09-23 | 2009-09-23 | Ligands for aggregated tau molecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2338059T3 true PL2338059T3 (pl) | 2015-10-30 |
Family
ID=41478644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09785147T PL2338059T3 (pl) | 2008-09-23 | 2009-09-23 | Ligandy dla zagregowanych cząsteczek tau |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8895313B2 (pl) |
| EP (1) | EP2338059B1 (pl) |
| JP (1) | JP5667058B2 (pl) |
| KR (1) | KR101631727B1 (pl) |
| CN (1) | CN102224423B (pl) |
| AU (1) | AU2009295701B2 (pl) |
| BR (1) | BRPI0919079B1 (pl) |
| CA (1) | CA2737028C (pl) |
| DK (1) | DK2338059T3 (pl) |
| ES (1) | ES2540536T3 (pl) |
| HK (1) | HK1159247A1 (pl) |
| HR (1) | HRP20150724T1 (pl) |
| IL (1) | IL211369A (pl) |
| MX (1) | MX2011002647A (pl) |
| PL (1) | PL2338059T3 (pl) |
| PT (1) | PT2338059E (pl) |
| RU (1) | RU2518892C2 (pl) |
| SI (1) | SI2338059T1 (pl) |
| WO (1) | WO2010034982A1 (pl) |
| ZA (1) | ZA201102159B (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2427463A1 (en) * | 2009-05-05 | 2012-03-14 | Limited Liability Company "Innovative Pharma" | Imidazo [1, 2 -a] pyridin-2 -yl-phenyl derivatives to be used in cancer treatment |
| CN102250134B (zh) * | 2010-05-21 | 2013-12-04 | 中国科学院化学研究所 | 一种识别氟离子的荧光探针及其制备方法和用途 |
| WO2012094334A1 (en) * | 2011-01-04 | 2012-07-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | One-step 18f labeling of biological substrates and uses of 18f labeled biological substrates |
| EP2671885A1 (en) * | 2012-06-05 | 2013-12-11 | Ares Trading S.A. | Imidazo-oxadiazole and Imidazo-thiadiazole derivatives |
| MX2015001546A (es) * | 2012-08-14 | 2015-05-11 | Hoffmann La Roche | Derivados de imidazo[2,1]tiazol-3-ona utiles como agentes de diagnostico para la enfermedad de alzheimer. |
| DK2767532T3 (en) * | 2012-12-21 | 2016-09-12 | Nat Inst For Quantum And Radiological Science And Tech | New connection for reproduction of tau protein heavy in the brain. |
| WO2014177458A1 (en) | 2013-04-29 | 2014-11-06 | F. Hoffmann-La Roche Ag | 2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES |
| WO2015044095A1 (en) * | 2013-09-26 | 2015-04-02 | F. Hoffmann-La Roche Ag | Imidazo[1,2-a]pyridin-7-amines as imaging tools |
| PL3197277T3 (pl) | 2014-08-29 | 2022-04-04 | Chdi Foundation, Inc. | Sondy do obrazowania molekularnego białka huntingtyny |
| CN104557768B (zh) * | 2014-12-09 | 2016-09-14 | 温州大学 | 一种苯并噻唑衍生物的合成方法 |
| EP3263109B1 (en) * | 2015-02-24 | 2020-06-17 | National University Corporation Tottori University | Drug for preventing and/or treating dementia |
| WO2016148114A1 (ja) * | 2015-03-13 | 2016-09-22 | 国立大学法人北海道大学 | 酸化ストレス誘導神経細胞死抑制化合物 |
| CA2994178C (en) * | 2015-08-18 | 2024-03-19 | The Regents Of The University Of California | Nitroxide containing amyloid binding agents for imaging and therapeutic uses |
| CN108276435B (zh) * | 2015-12-30 | 2020-04-14 | 南京中硼联康医疗科技有限公司 | 用于制备和β淀粉样蛋白特异性结合的化合物的中间体的制备方法 |
| CN106496275A (zh) * | 2016-09-07 | 2017-03-15 | 北京师范大学 | 与Aβ斑块具有高亲和力的N2S2类2‑芳基苯并噻唑化合物及其制备方法与应用 |
| GB201617339D0 (en) | 2016-10-12 | 2016-11-23 | Lytix Biopharma As | Therapeutic compounds |
| CA3048376A1 (en) | 2016-12-27 | 2018-07-05 | Riken | Bmp-signal-inhibiting compound |
| AU2019265346B2 (en) * | 2018-05-09 | 2022-06-16 | Aprinoia Therapeutics Limited | Heteroaryl compounds and uses thereof |
| KR102215255B1 (ko) * | 2019-06-12 | 2021-02-15 | 한국과학기술연구원 | 타우 응집체에 선택적으로 결합하는 형광 탐침자로서 유효한 신규 화합물 및 이의 제조 방법 |
| KR102132847B1 (ko) * | 2019-12-09 | 2020-07-13 | 한국과학기술연구원 | 타우 응집체에 높은 선택성을 가지는 화합물, 이를 포함하는 타우 표적 프로브, 및 이의 제조 방법 |
| GB202213796D0 (en) | 2022-09-21 | 2022-11-02 | Wista Lab Ltd | Tau aggregation inhibitors |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL265443A (pl) | 1960-06-02 | |||
| CH484918A (de) | 1965-10-28 | 1970-01-31 | Ciba Geigy | Verfahren zur Herstellung heterocyclischer, Aethylendoppelbindungen enthaltender Verbindungen |
| CH542266A (de) | 1966-09-23 | 1973-09-30 | Ciba Geigy Ag | Verwendung von Styryl-Verbindungen als optische Aufhellmittel für organische Materialien ausserhalb der Textilindustrie |
| US3615639A (en) * | 1967-10-23 | 1971-10-26 | Eastman Kodak Co | Direct positive silver halide emulsions containing dyes as electron acceptors and spectral sensitizers |
| JPS51102186A (pl) | 1975-03-06 | 1976-09-09 | Mitsui Toatsu Chemicals | |
| EP0002042B1 (de) | 1977-11-16 | 1980-10-29 | Hoechst Aktiengesellschaft | Diamino-1,3,5-triazinylstilbenverbindungen, Verfahren zu deren Herstellung und ihre Verwendung als optische Aufheller |
| DE3216723A1 (de) | 1982-05-05 | 1983-11-10 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von 4,4'-bis-benz-ox(-thi,-imid)-azol-2-yl-stilbenen |
| EP0287909B1 (en) | 1987-04-08 | 1992-09-02 | Salutar, Inc. | Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor |
| GB9503946D0 (en) | 1995-02-28 | 1995-04-19 | Cancer Res Campaign Tech | Benzazole compounds |
| AU6279100A (en) | 1999-08-09 | 2001-03-05 | Ciba Specialty Chemicals Holding Inc. | Benzothiazole compounds and their use as optical brighteners |
| EP1277729A4 (en) * | 2000-04-28 | 2005-05-11 | Sankyo Co | MODULATORS OF PPAR (GAMMA) |
| US6720324B2 (en) | 2000-07-05 | 2004-04-13 | Synaptic Pharmaceutical Corporation | Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
| GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| GB0106953D0 (en) * | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
| ATE364382T1 (de) * | 2001-08-13 | 2007-07-15 | Max Planck Gesellschaft | Hemmer der aggregation von polyq |
| JP2004067659A (ja) | 2002-06-12 | 2004-03-04 | Bf Kenkyusho:Kk | タウ蛋白蓄積性疾患の診断プローブとしてのベンゾイミダゾール環含有化合物 |
| AU2003261834A1 (en) | 2002-08-30 | 2004-05-04 | Bf Research Institute, Inc. | Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| EP1574500A1 (en) | 2002-12-16 | 2005-09-14 | BF Research Institute, Inc. | Quinoline derivative as diagnostic probe for disease with tau protein accumulation |
| AU2004221897B2 (en) * | 2003-03-14 | 2010-11-18 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Benzothiazole derivative compounds, compositions and uses |
| CA2438032C (en) * | 2003-03-14 | 2013-05-07 | University Of Pittsburgh | Benzothiazole derivative compounds, compositions and uses |
| WO2005033288A2 (en) | 2003-09-29 | 2005-04-14 | The Johns Hopkins University | Hedgehog pathway antagonists |
| EP1768709A1 (en) * | 2004-07-02 | 2007-04-04 | University of Pittsburgh | A method of diagnosing prodromal forms of diseases associated with amyloid deposition |
| ES2427963T3 (es) * | 2004-07-02 | 2013-11-05 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Uso de derivados de tioflavina radiomarcados en formación de imágenes de amiloide para evaluación de las terapias antiamiloide |
| US20070086949A1 (en) | 2005-06-20 | 2007-04-19 | Prasad Paras N | Method of bioimaging using nanocrystals of fluorescent dyes |
| WO2007019417A1 (en) | 2005-08-04 | 2007-02-15 | Sirtris Pharmaceuticals, Inc. | Oxazolopyridine derivatives as sirtuin modulators |
| GB0516564D0 (en) | 2005-08-12 | 2005-09-21 | Ge Healthcare Ltd | Fluorination process |
| EP2046122A4 (en) * | 2006-07-24 | 2009-12-23 | Univ Maryland | HEMOXYGENASE INHIBITORS AND METHOD FOR THEIR THERAPEUTIC APPLICATION |
| WO2008029152A2 (en) * | 2006-09-08 | 2008-03-13 | Summit Corporation Plc | Treatment of duchenne muscular dystrophy |
| RU2364597C1 (ru) | 2007-12-14 | 2009-08-20 | Андрей Александрович Иващенко | ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ |
| EP2427463A1 (en) | 2009-05-05 | 2012-03-14 | Limited Liability Company "Innovative Pharma" | Imidazo [1, 2 -a] pyridin-2 -yl-phenyl derivatives to be used in cancer treatment |
-
2009
- 2009-09-23 EP EP09785147.1A patent/EP2338059B1/en active Active
- 2009-09-23 SI SI200931224T patent/SI2338059T1/sl unknown
- 2009-09-23 DK DK09785147.1T patent/DK2338059T3/en active
- 2009-09-23 CA CA2737028A patent/CA2737028C/en active Active
- 2009-09-23 ES ES09785147.1T patent/ES2540536T3/es active Active
- 2009-09-23 PL PL09785147T patent/PL2338059T3/pl unknown
- 2009-09-23 PT PT97851471T patent/PT2338059E/pt unknown
- 2009-09-23 RU RU2011107931/04A patent/RU2518892C2/ru active
- 2009-09-23 CN CN200980146839.3A patent/CN102224423B/zh active Active
- 2009-09-23 MX MX2011002647A patent/MX2011002647A/es active IP Right Grant
- 2009-09-23 WO PCT/GB2009/002260 patent/WO2010034982A1/en active Application Filing
- 2009-09-23 JP JP2011527403A patent/JP5667058B2/ja active Active
- 2009-09-23 KR KR1020117009132A patent/KR101631727B1/ko active IP Right Grant
- 2009-09-23 US US13/063,525 patent/US8895313B2/en active Active
- 2009-09-23 AU AU2009295701A patent/AU2009295701B2/en active Active
- 2009-09-23 BR BRPI0919079-1A patent/BRPI0919079B1/pt active IP Right Grant
-
2011
- 2011-02-23 IL IL211369A patent/IL211369A/en active IP Right Grant
- 2011-03-23 ZA ZA2011/02159A patent/ZA201102159B/en unknown
- 2011-12-21 HK HK11113773.3A patent/HK1159247A1/xx unknown
-
2015
- 2015-07-03 HR HRP20150724TT patent/HRP20150724T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2338059T3 (en) | 2015-06-15 |
| CA2737028A1 (en) | 2010-04-01 |
| ES2540536T3 (es) | 2015-07-10 |
| KR20110076956A (ko) | 2011-07-06 |
| US20110171739A1 (en) | 2011-07-14 |
| EP2338059A1 (en) | 2011-06-29 |
| JP2012502966A (ja) | 2012-02-02 |
| IL211369A0 (en) | 2011-04-28 |
| RU2011107931A (ru) | 2012-10-27 |
| RU2518892C2 (ru) | 2014-06-10 |
| WO2010034982A1 (en) | 2010-04-01 |
| AU2009295701B2 (en) | 2014-07-24 |
| BRPI0919079A2 (pt) | 2020-08-18 |
| AU2009295701A1 (en) | 2010-04-01 |
| ZA201102159B (en) | 2012-10-31 |
| HRP20150724T1 (hr) | 2015-08-14 |
| PT2338059E (pt) | 2015-08-03 |
| EP2338059B1 (en) | 2015-04-08 |
| US8895313B2 (en) | 2014-11-25 |
| BRPI0919079B1 (pt) | 2022-02-15 |
| HK1159247A1 (en) | 2012-07-27 |
| CN102224423A (zh) | 2011-10-19 |
| SI2338059T1 (sl) | 2015-08-31 |
| CN102224423B (zh) | 2014-10-22 |
| KR101631727B1 (ko) | 2016-06-17 |
| CA2737028C (en) | 2017-06-27 |
| MX2011002647A (es) | 2011-04-07 |
| IL211369A (en) | 2015-07-30 |
| JP5667058B2 (ja) | 2015-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1159247A1 (en) | Ligands for aggregated tau molecules tau | |
| GB0815109D0 (en) | Polydialkylsiloxane-bridged bi-photochromic molecules | |
| GB2462159B (en) | Filtration media | |
| ZA201103027B (en) | Improved antibody molecules | |
| GB2463964B (en) | Composite filter media | |
| AP2012006188A0 (en) | Bispecific binding molecules for anti-angiogenesistherapy. | |
| GB0816310D0 (en) | Filter assembly | |
| SI2098275T1 (sl) | Filter | |
| EP2234662A4 (en) | FILTERED | |
| IL205673A0 (en) | Filter assembly | |
| HK1161570A1 (en) | Carbon block filter | |
| GB0823232D0 (en) | Filter assembly | |
| EP2302422A4 (en) | FILTER FOR DISPLAY DEVICE | |
| EP2280775A4 (en) | FILTER SEAL | |
| EP2361132A4 (en) | FILTER SET | |
| EP2315353A4 (en) | FILTER | |
| EP2361131A4 (en) | FILTER SET | |
| GB0814668D0 (en) | Filter | |
| EP2147042A4 (en) | DENDRITIC MOLECULES | |
| IL213675A0 (en) | Chiral ligands | |
| GB0920811D0 (en) | Clips | |
| EP2352650A4 (en) | IMPROVED SUPPORT APPLICATION | |
| GB0823420D0 (en) | a2-Adrenoceptor ligands | |
| IL212865A0 (en) | Chiral ligands | |
| ZA201009105B (en) | Filter assembly |